Indoor Biotechnologies产品代理

产品分类 > 科研试剂 > Indoor Biotechnologies产品代理

Indoor Biotechnologies产品代理

Indoor Biotechnologies 由弗吉尼亚大学前医学和微生物学教授、UVA 哮喘和过敏性疾病中心成员 Martin D. Chapman 博士创立。 Chapman 博士是美国过敏、哮喘和免疫学学会的研究员,并曾担任美国国立卫生研究院、环境保护署、学术机构和财富 500 强公司的顾问。
Indoor Biotechnologies 专门生产用于过敏和哮喘的生物制剂。 该公司被公认为评估过敏原环境暴露的世界领先者 - 在家庭、工作场所、学校和商业建筑中。 该公司生产用于过敏研究和诊断的高纯度过敏原,并在过敏原结构、功能和免疫识别方面的研究得到国际认可。 Indoor Biotechnologies 的使命是提高过敏和哮喘患者的生活质量。
价格: 0.00

Indoor Biotechnologies was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the 

American   Academy of Allergy, Asthma and Immunology and has served as a consultant to   the U.S. National Institutes of Health, the Environmental Protection Agency,   academic institutions and Fortune 500 companies..

   

Indoor Biotechnologies specializes in manufacturing biologics for allergy and asthma. The company is recognized as the world leader in assessment of environmental exposure to allergens - in the home, workplace, schools and commercial buildings. The company manufactures highly purified allergens for allergy research and diagnostics, and is internationally recognized for research on allergen structure, function and immune recognition. Indoor Biotechnologies mission is to improve the quality of life of patients with allergy and asthma.